Europe Radioimmunoassay Market - Industry Trends and Forecast to 2030

Description

List of Tables

Europe radioimmunoassay market is projected to register a substantial CAGR of 4.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Europe Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others), Country (Germany, France, U.K, Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and Rest of Europe) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of Europe radioimmunoassay market are:

Increase in the demand for error-free and accurate results of high throughput and automated procedures

Rise in the technological advancements

Strategic initiatives by market players

Increasing significance of research and development in medical science

Market Players:

The key market players in Europe radioimmunoassay market are listed below:

PerkinElmer Inc.

MP BIOMEDICALS

Tecan Trading AG

Merck KGaA

Immuno-Biological Laboratories Co,Ltd.

EUROIMMUN Medizinische Labordiagnostika AG

Beckman Coulter, Inc.

Demeditec Diagnostics GmbH

MyBioSource.com.

DiaSource

Berthold Technologies GmbH & Co.KG

Hidex Oy.

Institute of Isotopes

Abcam plc

1 INTRODUCTION 65

1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF EUROPE RADIOIMMUNOASSAY MARKET 65
1.4 LIMITATIONS 67
1.5 MARKETS COVERED 67

2 MARKET SEGMENTATION 71

2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 CURRENCY AND PRICING 73
2.5 DBMR TRIPOD DATA VALIDATION MODEL 74
2.6 MULTIVARIATE MODELLING 77
2.7 PRODUCT TYPE LIFELINE CURVE 77
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 78
2.9 DBMR MARKET POSITION GRID 79
2.10 MARKET TESTING TYPE COVERAGE GRID 81
2.11 VENDOR SHARE ANALYSIS 82
2.12 SECONDARY SOURCES 83
2.13 ASSUMPTIONS 83

3 EXECUTIVE SUMMARY 84

4 PREMIUM INSIGHTS 87

4.1 PESTEL ANALYSIS 88
4.2 PORTYER'S FIVE FORCES 89
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 90

5 INDUSTRY INSIGHTS: 91

6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92

6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 92
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 93
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 94

7 MARKET OVERVIEW 95

7.1 DRIVERS 97
- 7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 97
- 7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 97
- 7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 98
7.2 RESTRAINTS 98
- 7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 98
- 7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 99
- 7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 99
7.3 OPPORTUNITIES 100
- 7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 100
- 7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 100
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 101
7.4 CHALLENGES 103
- 7.4.1 LACK OF SKILLED PROFESSIONALS 103
- 7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 103

8 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 104

8.1 OVERVIEW 105
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 108
- 8.2.1 KITS 109
- 8.2.2 BUFFER 109
  - 8.2.2.1 SOLUTION 109
  - 8.2.2.2 POWDER 109
- 8.2.3 STANDARD CONCENTRATES 110
- 8.2.4 PRECIPITATING REAGENTS 110
- 8.2.5 RADIOISOTOPES 110
  - 8.2.5.1 BETA EMITTERS 110
    - 8.2.5.1.1 TRITIUM 110
    - 8.2.5.1.2 CARBON-14 111
  - 8.2.5.2 GAMMA EMITTERS 111
    - 8.2.5.2.1 IODINE-125 111
    - 8.2.5.2.2 CHROMIUM-51 111
    - 8.2.5.2.3 COBALT-57 111
- 8.2.6 ANTIBODY/ANTISERUM 112
  - 8.2.6.1 POLYCLONAL 112
  - 8.2.6.2 MONOCLONAL 112
- 8.2.7 OTHERS 112
8.3 RADIOIMMUNOASSAY ANALYZER 113

9 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION 114

9.1 OVERVIEW 115
9.2 SCIENTIFIC RESEARCH 118
- 9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 119
- 9.2.2 RADIOIMMUNOASSAY ANALYZER 119
9.3 CLINICAL DIAGNOSIS 119
- 9.3.1 INFECTIOUS DISEASE TESTING 120
  - 9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 120
  - 9.3.1.2 RADIOIMMUNOASSAY ANALYZER 120
- 9.3.2 ALLERGY TESTING 121
  - 9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
  - 9.3.2.2 RADIOIMMUNOASSAY ANALYZER 121
- 9.3.3 ONCOLOGY TESTING 121
  - 9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
  - 9.3.3.2 RADIOIMMUNOASSAY ANALYZER 122
- 9.3.4 ENDOCRINE TESTING 122
  - 9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
  - 9.3.4.2 RADIOIMMUNOASSAY ANALYZER 122
- 9.3.5 TOXICOLOGY TESTING 123
  - 9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
  - 9.3.5.2 RADIOIMMUNOASSAY ANALYZER 123
- 9.3.6 AUTOIMMUNE DISEASE TESTING 123
  - 9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
  - 9.3.6.2 RADIOIMMUNOASSAY ANALYZER 124
- 9.3.7 OTHER DISEASE TESTING 124

10 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER 125

10.1 OVERVIEW 126
10.2 HOSPITALS 129
10.3 CLINICAL DIAGNOSTIC LABORATORIES 129
10.4 ACADEMIC AND RESEARCH INSTITUTES 130
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 131
10.6 CONTRACT RESEARCH ORGANISATIONS 131
10.7 OTHERS 132

11 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 133

11.1 OVERVIEW 134
11.2 DIRECT TENDER 137
11.3 ONLINE SALES 138
11.4 THIRD PARTY DISTRIBUTIONS 139
11.5 OTHERS 140

12 EUROPE RADIOIMMUNOASSAY MARKET, BY REGION 141

12.1 EUROPE 142
- 12.1.1 GERMANY 154
- 12.1.2 FRANCE 162
- 12.1.3 U.K. 169
- 12.1.4 ITALY 176
- 12.1.5 SPAIN 183
- 12.1.6 RUSSIA 190
- 12.1.7 TURKEY 197
- 12.1.8 NETHERLANDS 204
- 12.1.9 BELGIUM 211
- 12.1.10 SWITZERLAND 219
- 12.1.11 REST OF EUROPE 226

13 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 227

13.1 COMPANY SHARE ANALYSIS: EUROPE 227

14 SWOT ANALYSIS 228

15 COMPANY PROFILE 229

15.1 PERKINELMER INC. 229
- 15.1.1 COMPANY SNAPSHOT 229
- 15.1.2 REVENUE ANALYSIS 229
- 15.1.3 COMPANY SHARE ANALYSIS 230
- 15.1.4 PRODUCT PORTFOLIO 230
- 15.1.4 RECENT DEVELOPMENT 231
15.2 MERCK KGAA 232
- 15.2.1 COMPANY SNAPSHOT 232
- 15.2.2 REVENUE ANALYSIS 232
- 15.2.3 COMPANY SHARE ANALYSIS 233
- 15.2.4 PRODUCT PORTFOLIO 233
- 15.2.5 RECENT DEVELOPMENTS 233
15.3 BECKMAN COULTER, INC. 235
- 15.3.1 COMPANY SNAPSHOT 235
- 15.3.2 COMPANY SHARE ANALYSIS 235
- 15.3.3 PRODUCT PORTFOLIO 235
- 15.3.4 RECENT DEVELOPMENT 236
15.4 ABCAM PLC 237
- 15.4.1 COMPANY SNAPSHOT 237
- 15.4.2 REVENUE ANALYSIS 237
- 15.4.3 COMPANY SHARE ANALYSIS 238
- 15.4.4 PRODUCT PORTFOLIO 238
- 15.4.5 RECENT DEVELOPMENT 238
15.5 TECAN TRADING AG 239
- 15.5.1 COMPANY SNAPSHOT 239
- 15.5.2 REVENUE ANALYSIS 239
- 15.5.3 COMPANY SHARE ANALYSIS 240
- 15.5.4 PRODUCT PORTFOLIO 240
- 15.5.5 RECENT DEVELOPMENT 241
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 242
- 15.6.1 COMPANY SNAPSHOT 242
- 15.6.2 PRODUCT PORTFOLIO 242
- 15.6.3 RECENT DEVELOPMENTS 242
15.7 DEMEDITEC DIAGNOSTICS GMBH 243
- 15.7.1 COMPANY SNAPSHOT 243
- 15.7.2 PRODUCT PORTFOLIO 243
- 15.7.3 RECENT DEVELOPMENTS 244
15.8 DIASOURCE 245
- 15.8.1 COMPANY SNAPSHOT 245
- 15.8.2 PRODUCT PORTFOLIO 245
- 15.8.3 RECENT DEVELOPMENT 245
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 246
- 15.9.1 COMPANY SNAPSHOT 246
- 15.9.2 PRODUCT PORTFOLIO 246
- 15.9.3 RECENT DEVELOPMENTS 246
15.10 HIDEX OY 248
- 15.10.1 COMPANY SNAPSHOT 248
- 15.10.2 PRODUCT PORTFOLIO 248
- 15.10.3 RECENT DEVELOPMENTS 248
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 249
- 15.11.1 COMPANY SNAPSHOT 249
- 15.11.2 PRODUCT PORTFOLIO 249
- 15.11.3 RECENT DEVELOPMENT 251
15.12 INSTITUTE OF ISOTOPES 252
- 15.12.1 COMPANY SNAPSHOT 252
- 15.12.2 PRODUCT PORTFOLIO 252
- 15.12.3 RECENT DEVELOPMENTS 253
15.13 KAMIYA BIOMEDICAL COMPANY 254
- 15.13.1 COMPANY SNAPSHOT 254
- 15.13.2 PRODUCT PORTFOLIO 254
- 15.13.3 RECENT DEVELOPMENTS 254
15.14 MP BIOMEDICALS 255
- 15.14.1 COMPANY SNAPSHOT 255
- 15.14.2 PRODUCT PORTFOLIO 255
- 15.14.3 RECENT DEVELOPMENTS 256
15.15 MYBIOSOURCE.COM. 257
- 15.15.1 COMPANY SNAPSHOT 257
- 15.15.2 PRODUCT PORTFOLIO 257
- 15.15.3 RECENT DEVELOPMENT 257

16 QUESTIONNAIRE 258

17 RELATED REPORTS 261

LIST OF TABLES

TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 58
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 63
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 64
TABLE 4 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
TABLE 5 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 73
TABLE 6 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 7 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 74
TABLE 8 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 9 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 75
TABLE 10 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 76
TABLE 11 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 77
TABLE 12 EUROPE RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 13 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 82
TABLE 14 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 15 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 83
TABLE 16 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 17 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 18 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 85
TABLE 19 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 20 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 86
TABLE 21 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 87
TABLE 22 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 88
TABLE 23 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 88
TABLE 24 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 93
TABLE 25 EUROPE HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 26 EUROPE CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 27 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 29 EUROPE CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 30 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 101
TABLE 32 EUROPE DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 EUROPE ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 34 EUROPE THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 35 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 36 EUROPE RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 111
TABLE 37 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 38 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 39 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 40 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 41 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 42 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 43 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 44 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 45 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 46 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 47 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 113
TABLE 48 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 49 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 50 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 51 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 114
TABLE 52 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 114
TABLE 53 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 114
TABLE 54 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 55 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 56 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 57 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 58 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 59 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 60 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 61 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 62 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 63 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 117
TABLE 64 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 65 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 66 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 67 GERMANY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 68 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 69 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 119
TABLE 70 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 71 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 72 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 120
TABLE 73 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 74 GERMANY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 75 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 76 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 77 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 78 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 79 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 80 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 81 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 122
TABLE 82 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 122
TABLE 83 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 122
TABLE 84 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 123
TABLE 85 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 123
TABLE 86 GERMANY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 87 GERMANY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 88 GERMANY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
TABLE 89 GERMANY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 90 GERMANY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 91 GERMANY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 92 GERMANY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 93 GERMANY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 125
TABLE 94 GERMANY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 95 GERMANY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 126
TABLE 96 GERMANY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 126
TABLE 97 FRANCE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 98 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 99 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 127
TABLE 100 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 101 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 102 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 128
TABLE 103 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 128
TABLE 104 FRANCE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 128
TABLE 105 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 106 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 107 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 129
TABLE 108 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 109 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 129
TABLE 110 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 130
TABLE 111 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 130
TABLE 112 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 130
TABLE 113 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 130
TABLE 114 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 130
TABLE 115 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 131
TABLE 116 FRANCE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 117 FRANCE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 118 FRANCE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 119 FRANCE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 120 FRANCE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 121 FRANCE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 122 FRANCE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 123 FRANCE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 133
TABLE 124 FRANCE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 125 FRANCE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 133
TABLE 126 FRANCE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 127 U.K. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 128 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 129 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 134
TABLE 130 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 131 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 132 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 135
TABLE 133 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 135
TABLE 134 U.K. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 135 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 136 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 136
TABLE 137 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 136

TABLE 138 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
TABLE 139 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 136
TABLE 140 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 137
TABLE 141 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 137
TABLE 142 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 137
TABLE 143 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 137
TABLE 144 U.K. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 137
TABLE 145 U.K. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 138
TABLE 146 U.K. RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
TABLE 147 U.K. SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 138
TABLE 148 U.K. CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
TABLE 149 U.K. INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 150 U.K. ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 151 U.K. ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 152 U.K. ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 153 U.K. TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 140
TABLE 154 U.K. AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 155 U.K. RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 140
TABLE 156 U.K. RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 140
TABLE 157 ITALY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 158 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
TABLE 159 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 141
TABLE 160 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 142
TABLE 161 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 162 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 142
TABLE 163 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 142
TABLE 164 ITALY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
TABLE 165 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 166 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 143
TABLE 167 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 143
TABLE 168 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 143
TABLE 169 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 143
TABLE 170 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 144
TABLE 171 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 144
TABLE 172 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 144
TABLE 173 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 144
TABLE 174 ITALY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 144
TABLE 175 ITALY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 145
TABLE 176 ITALY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 177 ITALY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 178 ITALY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 179 ITALY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 180 ITALY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 181 ITALY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 182 ITALY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
TABLE 183 ITALY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 147
TABLE 184 ITALY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
TABLE 185 ITALY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 147
TABLE 186 ITALY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 187 SPAIN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 188 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 148
TABLE 189 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 148
TABLE 190 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 149
TABLE 191 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 192 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 149
TABLE 193 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 149
TABLE 194 SPAIN RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 195 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 196 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 150
TABLE 197 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 150
TABLE 198 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 199 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 150
TABLE 200 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 151
TABLE 201 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 151
TABLE 202 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 151
TABLE 203 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 151
TABLE 204 SPAIN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 151
TABLE 205 SPAIN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 152
TABLE 206 SPAIN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 207 SPAIN SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
TABLE 208 SPAIN CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 209 SPAIN INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 210 SPAIN ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 211 SPAIN ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 212 SPAIN ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 153
TABLE 213 SPAIN TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 154
TABLE 214 SPAIN AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
TABLE 215 SPAIN RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 154
TABLE 216 SPAIN RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 154
TABLE 217 RUSSIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 218 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 219 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 155
TABLE 220 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 156
TABLE 221 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 222 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 156
TABLE 223 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 156
TABLE 224 RUSSIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
TABLE 225 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 226 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 157
TABLE 227 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 157
TABLE 228 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
TABLE 229 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 157
TABLE 230 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 158
TABLE 231 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 158
TABLE 232 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 158
TABLE 233 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 158
TABLE 234 RUSSIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 158
TABLE 235 RUSSIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 159
TABLE 236 RUSSIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
TABLE 237 RUSSIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 238 RUSSIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
TABLE 239 RUSSIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 240 RUSSIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 241 RUSSIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 242 RUSSIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 243 RUSSIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 161
TABLE 244 RUSSIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 161
TABLE 245 RUSSIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 161
TABLE 246 RUSSIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 161
TABLE 247 TURKEY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 248 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
TABLE 249 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 162
TABLE 250 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 162
TABLE 251 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163

LIST OF FIGURES

FIGURE 1 EUROPE RADIOIMMUNOASSAY MARKET: SEGMENTATION 35
FIGURE 2 EUROPE RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION 38
FIGURE 3 EUROPE RADIOIMMUNOASSAY MARKET: DROC ANALYSIS 39
FIGURE 4 EUROPE RADIOIMMUNOASSAY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 40
FIGURE 5 EUROPE RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS 40
FIGURE 6 EUROPE RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS 42
FIGURE 7 EUROPE RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID 43
FIGURE 8 EUROPE RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID 45
FIGURE 9 EUROPE RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS 46
FIGURE 10 EUROPE RADIOIMMUNOASSAY MARKET: SEGMENTATION 50
FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE EUROPE RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD 51
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOIMMUNOASSAY MARKET IN 2023 & 2030 51
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE RADIOIMMUNOASSAY MARKET 60
FIGURE 14 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022 69
FIGURE 15 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 70
FIGURE 16 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 70
FIGURE 17 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE 71
FIGURE 18 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022 79
FIGURE 19 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 80
FIGURE 20 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030) 80
FIGURE 21 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE 81
FIGURE 22 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, 2022 90
FIGURE 23 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION) 91
FIGURE 24 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030) 91
FIGURE 25 EUROPE RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE 92
FIGURE 26 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022 98
FIGURE 27 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 99
FIGURE 28 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 99
FIGURE 29 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 100
FIGURE 30 EUROPE RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 107
FIGURE 31 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 108
FIGURE 32 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 108
FIGURE 33 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 109
FIGURE 34 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 109
FIGURE 35 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%) 191